These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 11455504)

  • 1. Comparison of in-vitro activities of SCH27899 and other antibiotics against Mycoplasma pneumoniae.
    Ikejima H; Yamamoto H; Ishida K; Terakubo S; Kaku M; Shimada J
    J Infect Chemother; 2001 Jun; 7(2):121-3. PubMed ID: 11455504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of in-vitro activity of new quinolones, macrolides, and minocycline against Mycoplasma pneumoniae.
    Ikejima H; Yamamoto H; Ishida K; Kaku M; Shimada J
    J Infect Chemother; 2000 Sep; 6(3):148-50. PubMed ID: 11810555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of levofloxacin against contemporary clinical isolates of Legionella pneumophila, Mycoplasma pneumoniae and Chlamydia pneumoniae from North America and Europe.
    Critchley IA; Jones ME; Heinze PD; Hubbard D; Engler HD; Evangelista AT; Thornsberry C; Karlowsky JA; Sahm DF
    Clin Microbiol Infect; 2002 Apr; 8(4):214-21. PubMed ID: 12047413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of telithromycin (HMR3647), a new ketolide, against clinical isolates of Mycoplasma pneumoniae in Japan.
    Yamaguchi T; Hirakata Y; Izumikawa K; Miyazaki Y; Maesaki S; Tomono K; Yamada Y; Kamihira S; Kohno S
    Antimicrob Agents Chemother; 2000 May; 44(5):1381-2. PubMed ID: 10770785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo activities of macrolides against Mycoplasma pneumoniae.
    Ishida K; Kaku M; Irifune K; Mizukane R; Takemura H; Yoshida R; Tanaka H; Usui T; Suyama N; Tomono K
    Antimicrob Agents Chemother; 1994 Apr; 38(4):790-8. PubMed ID: 8031048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory and bactericidal activities of gemifloxacin and other antimicrobials against Mycoplasma pneumoniae.
    Waites KB; Crabb DM; Duffy LB
    Int J Antimicrob Agents; 2003 Jun; 21(6):574-7. PubMed ID: 12791472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance of Mycoplasma pneumoniae to macrolide and analogous antibiotics.
    Suzaki K
    Sci Rep Res Inst Tohoku Univ Med; 1979 Dec; 26(3-4):71-91. PubMed ID: 121168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Killing kinetics of minocycline, doxycycline and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae.
    Morozumi M; Okada T; Tajima T; Ubukata K; Iwata S
    Int J Antimicrob Agents; 2017 Aug; 50(2):255-257. PubMed ID: 28579455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of an evernimicin derivative, SCH27899, against anaerobic bacteria and Propionibacterium acnes.
    Tanaka K; Kato N; Watanabe K
    J Antimicrob Chemother; 2000 Sep; 46(3):465-9. PubMed ID: 10980176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of twenty penicillin-susceptible and -resistant pneumococci to levofloxacin, ciprofloxacin, ofloxacin, erythromycin, azithromycin, and clarithromycin by MIC and time-kill.
    Visalli MA; Jacobs MR; Appelbaum PC
    Diagn Microbiol Infect Dis; 1997 Jul; 28(3):131-7. PubMed ID: 9294703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of a rapid diagnosis kit for Mycoplasma pneumoniae pneumonia in children, and the antimicrobial susceptibility of the isolates.
    Ozaki T; Nishimura N; Ahn J; Watanabe N; Muto T; Saito A; Koyama N; Nakane K; Funahashi K
    J Infect Chemother; 2007 Aug; 13(4):204-7. PubMed ID: 17721681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic efficacy of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients.
    Ishiguro N; Koseki N; Kaiho M; Ariga T; Kikuta H; Togashi T; Oba K; Morita K; Nagano N; Nakanishi M; Hara K; Hazama K; Watanabe T; Yamanaka T; Sasaki S; Furuyama H; Shibata M; Shida S; Ishizaka A; Tabata Y; Aoyagi H; Naito H; Yoshioka M; Horino A; Kenri T;
    PLoS One; 2017; 12(3):e0173635. PubMed ID: 28288170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro antimicrobial activities of new quinolone antibiotics against Mycoplasma pneumoniae].
    Gohara Y; Arai S; Kuwano K; Kawashima T; Matsu-Ura I
    Nihon Saikingaku Zasshi; 1992 Mar; 47(2):387-93. PubMed ID: 1318981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with erythromycin in vitro.
    Okazaki N; Narita M; Yamada S; Izumikawa K; Umetsu M; Kenri T; Sasaki Y; Arakawa Y; Sasaki T
    Microbiol Immunol; 2001; 45(8):617-20. PubMed ID: 11592636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro and in-vivo activity of a new quinolone AM-1155 against Mycoplasma pneumoniae.
    Ishida K; Kaku M; Irifune K; Mizukane R; Takemura H; Yoshida R; Tanaka H; Usui T; Tomono K; Suyama N
    J Antimicrob Chemother; 1994 Dec; 34(6):875-83. PubMed ID: 7730231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in vitro activity of azithromycin, clarithromycin, erythromycin and lomefloxacin against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum.
    Renaudin H; Bébéar C
    Eur J Clin Microbiol Infect Dis; 1990 Nov; 9(11):838-41. PubMed ID: 1964899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo activities of Q-35, a new fluoroquinolone, against Mycoplasma pneumoniae.
    Gohara Y; Arai S; Akashi A; Kuwano K; Tseng CC; Matsubara S; Matumoto M; Furudera T
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1826-30. PubMed ID: 8239590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of macrolide-resistant Mycoplasma pneumoniae with a 23S rRNA gene mutation.
    Morozumi M; Hasegawa K; Kobayashi R; Inoue N; Iwata S; Kuroki H; Kawamura N; Nakayama E; Tajima T; Shimizu K; Ubukata K
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2302-6. PubMed ID: 15917525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activities of quinupristin-dalfopristin and the streptogramin RPR 106972 against Mycoplasma pneumoniae.
    Izumikawa K; Hirakata Y; Yamaguchi T; Yoshida R; Tanaka H; Takemura H; Maesaki S; Tomono K; Kaku M; Izumikawa KI; Kamihira S; Kohno S
    Antimicrob Agents Chemother; 1998 Mar; 42(3):698-9. PubMed ID: 9517955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activities of moxifloxacin and other fluoroquinolones against Mycoplasma pneumoniae.
    Hamamoto K; Shimizu T; Fujimoto N; Zhang Y; Arai S
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1908-10. PubMed ID: 11353651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.